International Journal of STD & AIDS > Volume 20, Number 6 > Pp. 399-405

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Bao, Y-P Articles by Liu, Z-M PubMed PubMed Citation Social Bookmarking                      What's this?

Original research articles

Systematic review of HIV and HCV infection among drug users in China

Y-P Bao PhD and Z-M Liu MD 

National Institute on Drug Dependence, Peking University, Beijing, 100191, China

Correspondence to: Dr Z-M Liu MD, National Institute on Drug Dependence, Peking University, 38, Xue Yuan Road, Hai Dian District, Beijing 100191, China Email: zhiminliu{at}bjmu.edu.cn

To determine the HIV and hepatitis C virus (HCV) geographical distribution among drug users in China, a systematic literature review of 40 peer-reviewed publications (comprising 15,565 drug users) was conducted. Of the total drug users, 10,724 were found to be injection drug users (IDUs) and 4841 were non-injection drug users (non-IDUs). Various studies identified that among IDUs and non-IDUs, the overall HIV prevalence rates were 12.55% and 1.05%, and the HCV prevalence rates were 66.97% and 18.30%, respectively. The HIV prevalence rate ranged from 0% (Anhui and Inner Mongolia) to 52.51% (Yunnan) among IDUs, and from 0% to 19.80% among non-IDUs correspondingly. The HCV prevalence rate ranged from 11.43% (Shannxi) to 90.77% (Hubei) among IDUs, and from 0% (Anhui) to 40.00% (Fujian) among non-IDUs. Based on the high prevalence of HIV and HCV among drug users, scaling-up harm reduction was required from ‘heroin trafficking areas’ to other areas in China.

Key Words: human immunodeficiency virus (HIV) • hepatitis C virus (HCV) • prevalence rate • drug users • China

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?